Challenges for biomedical informatics and pharmacogenomics

被引:53
作者
Altman, RB [1 ]
Klein, TE [1 ]
机构
[1] Stanford Med Informat, Stanford, CA 94305 USA
关键词
bioinformatics; pharmacogenetics; computation; databases;
D O I
10.1146/annurev.pharmtox.42.082401.140850
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmacogenomics requires the integration and analysis of genomic, molecular, cellular, and clinical data, and it thus offers a remarkable set of challenges to biomedical informatics. These include infrastructural challenges such as the creation of data models and databases for storing these data, the integration of these data with external databases, the extraction of information from natural language text, and the protection of databases with sensitive information. There are also scientific challenges in creating tools to support gene expression analysis, three-dimensional structural analysis, and comparative genomic analysis. In this review, we summarize the current uses of informatics within pharmacogenomics and show how the technical challenges that remain for biomedical informatics are typical of those that will be confronted in the postgenomic era.
引用
收藏
页码:113 / 133
页数:21
相关论文
共 116 条
[71]  
Murphy M P, 2000, Pharmacogenomics, V1, P115, DOI 10.1517/14622416.1.2.115
[72]   Prospective GYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trial [J].
Murphy, MP ;
Beaman, ME ;
Clark, LS ;
Cayouette, M ;
Benson, L ;
Morris, DM ;
Polli, JW .
PHARMACOGENETICS, 2000, 10 (07) :583-590
[73]  
Musen MA, 1998, METHOD INFORM MED, V37, P540
[74]   Organization of heterogeneous scientific data using the EAV/CR representation [J].
Nadkarni, PM ;
Marenco, L ;
Chen, R ;
Skoufos, E ;
Shepherd, G ;
Miller, P .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 1999, 6 (06) :478-493
[75]   THE P450 SUPERFAMILY - UPDATE ON NEW SEQUENCES, GENE-MAPPING, ACCESSION NUMBERS, EARLY TRIVIAL NAMES OF ENZYMES, AND NOMENCLATURE [J].
NELSON, DR ;
KAMATAKI, T ;
WAXMAN, DJ ;
GUENGERICH, FP ;
ESTABROOK, RW ;
FEYEREISEN, R ;
GONZALEZ, FJ ;
COON, MJ ;
GUNSALUS, IC ;
GOTOH, O ;
OKUDA, K ;
NEBERT, DW .
DNA AND CELL BIOLOGY, 1993, 12 (01) :1-51
[76]   P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature [J].
Nelson, DR ;
Koymans, L ;
Kamataki, T ;
Stegeman, JJ ;
Feyereisen, R ;
Waxman, DJ ;
Waterman, MR ;
Gotoh, O ;
Coon, MJ ;
Estabrook, RW ;
Gunsalus, IC ;
Nebert, DW .
PHARMACOGENETICS, 1996, 6 (01) :1-42
[77]  
Nolan P M, 2000, Pharmacogenomics, V1, P243, DOI 10.1517/14622416.1.3.243
[78]   The promise of comparative genomics in mammals [J].
O'Brien, SJ ;
Menotti-Raymond, M ;
Murphy, WJ ;
Nash, WG ;
Wienberg, J ;
Stanyon, R ;
Copeland, NG ;
Jenkins, NA ;
Womack, JE ;
Graves, JAM .
SCIENCE, 1999, 286 (5439) :458-+
[79]   PREDICTION OF THE BINDING-SITE OF 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE IN ACETYLCHOLINESTERASE BY DOCKING STUDIES WITH THE SYSDOC PROGRAM [J].
PANG, YP ;
KOZIKOWSKI, AP .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1994, 8 (06) :683-693
[80]   Mass spectrometry innovations in drug discovery and development [J].
Papac, DI ;
Shahrokh, Z .
PHARMACEUTICAL RESEARCH, 2001, 18 (02) :131-145